Building on previous achievements on HIV quality improvement (QI) and quality management (QM) initiatives of CDC-Ethiopia and Ethiopia’s Federal Ministry of Health (FMOH), this Funding Opportunity Announcement (FOA) will strengthen HIV QI/QM systems of FMOH, regional health bureaus (RHBs), and scale-up and maintenance of sub-national units and health facilities.
The purpose of this announcement is to solicit applications for the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), AIDS Education and Training Center National Clinician Consultation Center (AETC NCCC), a component of the HRSA AIDS Education and Training Center (AETC) Program.
The purpose of this FOA is to provide critical HR services and support to recruit suitably qualified and experienced individuals, consultants, and organizations and increase the competencies of MOHSS staff in HR policies, procedures, management and practices to meet PEPFAR objectives and achieve HIV epidemic control in Namibia.
The purpose of this FOA is to provide comprehensive and cost-effective capacity building and implementation of national surveillance surveys and impact evaluations of CDC-supported activities in Malawi. Through this FOA, the awardee will support the MOH and PHIM to build sustainable long-term capacity for the generation and use of surveillance data.
The purpose of this FOA is to accelerate the implementation of activities to attain epidemic control of HIV in prioritized geographic areas by directly supporting service delivery and adopting data driven processes to increase ART coverage.
In the Caribbean, the HIV/AIDS epidemic is concentrated among KP, including MSM, SW and TG individuals. Within a TA framework, CDC CRO aims to support MOHs as they strive to reach the UNAIDS 90:90:90 targets. This FOA will expand the capacity of Caribbean MOHs to strategically address the HIV epidemics by supporting sustainable national efforts to improve and scale up high impact combination prevention along the HIV COPCT.
This project will support an evaluation of up to two locally-developed or adapted and potentially effective but insufficiently evaluated, interventions that are designed to deliver a combination of HIV prevention, HIV care and treatment, and other social and structural support services to transgender persons who have sex with men who are at risk for HIV infection or who are living with HIV.
This Funding Opportunity Announcement (FOA) on the Human Immunology Project Consortium (HIPC) solicits applications from single institutions, or consortia of institutions, to participate in a network of human immunology profiling research groups in the area of infectious diseases, including HIV. The purpose of this FOA is to characterize human immune responses/mechanisms elicited by vaccinations, adjuvants or natural infection by capitalizing on recent advances in immune profiling technologies.
The goal of this Funding Opportunity Announcement (FOA) is to support innovative, basic and translational, nonexempt human subjects research in two areas, gastrointestinal (GI) mucosal immunology and liver disease. The emphasis for GI mucosal immunology is on elucidation of mechanisms whereby innate and adaptive immunity in the GI tract interacts with HIV infection in the presence or absence of antiretroviral therapy (ART) and contributes to GI pathology.
The goal of this Funding Opportunity Announcement (FOA) is to support innovative research in humans to elucidate the role of HIV infection, including relevant host conditions or antiretroviral therapy, on metabolic and endocrine dysfunction, as well as to support innovative research delineating the pathophysiology, etiology, risk or protective factors, and potential strategies to prevent, treat, or reverse endocrine and metabolic dysfunction in HIV-infected individuals. Proposed projects must involve human subjects with HIV infection or materials or data from HIV-infected individuals.